Cargando…

Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department

BACKGROUND: Antipseudomonal antibiotics should be restricted to patients at risk of Pseudomonas aeruginosa infection. However, the indications in different guidelines on community-acquired pneumonia (CAP) are discordant. Our objectives were to assess the prevalence of antipseudomonal antibiotic pres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angrill, Nuria, Gallego, Miguel, Font, Juli, Vallés, Jordi, Morón, Anisi, Monsó, Eduard, Rello, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126131/ https://www.ncbi.nlm.nih.gov/pubmed/32245452 http://dx.doi.org/10.1186/s12890-020-1115-0

Ejemplares similares

Evaluation of the Empiric use of Levofloxacin in Combination with Antipseudomonal Β-Lactams for the Treatment of Pneumonia
por: Bachna, Jon, et al.
Publicado: (2017)

Utilizing Monte Carlo Simulations to Optimize Institutional Empiric Antipseudomonal Therapy
por: Tennant, Sarah J., et al.
Publicado: (2015)

Clinical Outcomes of Antipseudomonal vs. Non-Antipseudomonal Therapy in Patients with Osteomyelitis
por: Jansen, Jeffrey W, et al.
Publicado: (2017)

Combination antibiotic therapy for community-acquired pneumonia
por: Caballero, Jesus, et al.
Publicado: (2011)

Improvement of antibiotic therapy and ICU survival in severe non-pneumococcal community-acquired pneumonia: a matched case–control study
por: Gattarello, Simone, et al.
Publicado: (2015)

Antipseudomonal β-Lactams Resistance in Iran
por: Rabiei, Mohammad Mahdi, et al.
Publicado: (2020)

An evaluation of antipseudomonal dosing on the incidence of treatment failure
por: Hawkins, Brandon K, et al.
Publicado: (2021)

Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems
por: Rudilla, Héctor, et al.
Publicado: (2016)

Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
por: Pomares, Xavier, et al.
Publicado: (2011)

Hospital-level variation in the utilization of antipseudomonal antibiotics: A nationwide cross-sectional study at the VHA
por: Hasegawa, Shinya, et al.
Publicado: (2022)

Impact of a syndrome-specific antibiotic stewardship intervention on antipseudomonal antibiotic use in inpatient diabetic foot infection management
por: McCreery, Randy J., et al.
Publicado: (2023)

Quorum Quenching: A Potential Target for Antipseudomonal Therapy
por: Hemmati, Fatemeh, et al.
Publicado: (2020)

Demographics, guidelines, and clinical experience in severe community-acquired pneumonia
por: Rello, Jordi
Publicado: (2008)

The simple and the simpler in pneumonia diagnosis
por: Lisboa, Thiago, et al.
Publicado: (2007)

Bench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumonia
por: Rello, Jordi
Publicado: (2005)

The influence of chest X-ray results on antibiotic prescription for childhood pneumonia in the emergency department
por: van de Maat, Josephine S., et al.
Publicado: (2021)

Clinical review: Primary influenza viral pneumonia
por: Rello, Jordi, et al.
Publicado: (2009)

Glucocorticoids and antibiotics, how do they get together?
por: Reidl, Joachim, et al.
Publicado: (2015)

KDEON WK-11: A short antipseudomonal peptide with promising potential
por: Casciaro, Bruno, et al.
Publicado: (2022)

Choosing the right combination therapy in severe community-acquired pneumonia
por: Waterer, Grant W, et al.
Publicado: (2006)

Pseudomonas aeruginosa ventilator-associated pneumonia management
por: Ramírez-Estrada, Sergio, et al.
Publicado: (2016)

Community-acquired bacterial pneumonia in adults: An update
por: Eshwara, Vandana Kalwaje, et al.
Publicado: (2020)

Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
por: Hong, Mai-Chi, et al.
Publicado: (2013)

Antipseudomonal Drug Exposure Associated with MDR Organisms in the Liver and Lung Transplant Population
por: Mulugeta, Surafel G, et al.
Publicado: (2017)

Management of Pseudomonas aeruginosa pneumonia: one size does not fit all
por: Rello, Jordi, et al.
Publicado: (2014)

Burden of Community-Acquired Pneumonia and Unmet Clinical Needs
por: Ferreira-Coimbra, João, et al.
Publicado: (2020)

Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
por: Swanson, Joseph M., et al.
Publicado: (2013)

Antipseudomonal Versus Narrow-Spectrum Agents for the Treatment of Community-Onset Intra-abdominal Infections
por: Worden, Lacy J, et al.
Publicado: (2021)

Steroids in severe community-acquired pneumonia: dangerous, worthless, or miracle cure? The roller coaster of clinical trials
por: Bouras, Marwan, et al.
Publicado: (2023)

Antibiotic prescription consistent with guidelines in emergency department is associated with 30-day survival in severe community-acquired pneumonia
por: Kang, Seung Hyun, et al.
Publicado: (2021)

Changes in antibiotic prescription following an education strategy for acute respiratory infections
por: Delsors, Eloisa, et al.
Publicado: (2021)

Evaluating the Nephrotoxicity of Area-under-the-Curve-Based Dosing of Vancomycin with Concomitant Antipseudomonal Beta-Lactam Antibiotics: A Systematic Review and Meta-Analysis
por: Chiu, Chia-Yu, et al.
Publicado: (2023)

Systemic antibiotics for preventing ventilator-associated pneumonia in comatose patients: a systematic review and meta-analysis
por: Righy, Cássia, et al.
Publicado: (2017)

Evaluation of Antibiotic Prophylaxis and Discharge Prescriptions in the General Surgery Department
por: Karaali, Cem, et al.
Publicado: (2019)

New insights into pneumonia in patients on prolonged mechanical ventilation: need for a new paradigm addressing dysbiosis
por: Rello, Jordi, et al.
Publicado: (2021)

Clinical review: Balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use
por: Slama, Thomas G
Publicado: (2008)

400 Beyond the Antibiogram: Using Monte Carlo Analysis to Optimize Institution-Specific Antipseudomonal Therapy
por: Tennant, Sarah, et al.
Publicado: (2014)

2175. In vitro Potency of Ceftolozane/Tazobactam and Other Antipseudomonal β-Lactams Against P. aeruginosa
por: Abuhussain, Safa Almarzoky, et al.
Publicado: (2018)

Antipseudomonal and Immunomodulatory Properties of Esc Peptides: Promising Features for Treatment of Chronic Infectious Diseases and Inflammation
por: Cappiello, Floriana, et al.
Publicado: (2021)

695. Antipseudomonal Versus Narrow-spectrum Agents for the Treatment of Community-onset Intra-abdominal Infections
por: Worden, Lacy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lsot7vm04g4foe872s3rfd2qt6